Your browser doesn't support javascript.
loading
Tobacco dependence treatment for special populations: challenges and opportunities
Castaldelli-Maia, João M.; Harutyunyan, Arusyak; Herbec, Aleksandra; Kessel, Tzvia; Odukoya, Oluwakemi; Kemper, Katherine E.; Hays, J.T.; Vardavas, Constantine.
  • Castaldelli-Maia, João M.; Clínica Clima. São Paulo. BR
  • Harutyunyan, Arusyak; Mayo Clinic. Global Bridges Healthcare Alliance for Tobacco Dependence Treatment. Rochester. US
  • Herbec, Aleksandra; Mayo Clinic. Global Bridges Healthcare Alliance for Tobacco Dependence Treatment. Rochester. US
  • Kessel, Tzvia; Mayo Clinic. Global Bridges Healthcare Alliance for Tobacco Dependence Treatment. Rochester. US
  • Odukoya, Oluwakemi; Mayo Clinic. Global Bridges Healthcare Alliance for Tobacco Dependence Treatment. Rochester. US
  • Kemper, Katherine E.; Mayo Clinic. Global Bridges Healthcare Alliance for Tobacco Dependence Treatment. Rochester. US
  • Hays, J.T.; Mayo Clinic. Global Bridges Healthcare Alliance for Tobacco Dependence Treatment. Rochester. US
  • Vardavas, Constantine; Mayo Clinic. Global Bridges Healthcare Alliance for Tobacco Dependence Treatment. Rochester. US
Braz. J. Psychiatry (São Paulo, 1999, Impr.) ; 43(1): 75-82, Jan.-Feb. 2021. tab
Artículo en Inglés | LILACS | ID: biblio-1153285
ABSTRACT
Although smoking rates have declined in most of the countries in the world, there are population groups within these countries whose smoking rates remain significantly higher than the general population. These "forgotten groups" who have not been receiving the needed attention in tobacco control policies and tobacco cessation efforts include people with serious mental illness, substance use disorders, tuberculosis, people living with human immunodeficiency virus (HIV), lesbian-gay-bisexual-transgender-queer people, and pregnant women. A number of steps are needed at the national level in countries where these disparities exist, including modifications to national smoking cessation treatment guidelines that address the special needs of these populations, as well as targeted smoking cessation research, since these populations are often not included in clinical trials. Because of the higher smoking prevalence in these populations, as well as their lower smoking cessation treatment success rates than the general population, more resources are needed if we are to reduce health disparities in these vulnerable populations. Additionally, we believe that more effort should be focused on integrating smoking cessation treatment in the specialized care settings frequented by these subpopulations.
Asunto(s)


Texto completo: Disponible Índice: LILACS (Américas) Asunto principal: Tabaquismo / Cese del Hábito de Fumar / Homosexualidad Femenina Tipo de estudio: Guía de Práctica Clínica / Factores de riesgo Idioma: Inglés Revista: Braz. J. Psychiatry (São Paulo, 1999, Impr.) Asunto de la revista: Psiquiatria Año: 2021 Tipo del documento: Artículo País de afiliación: Brasil / Estados Unidos Institución/País de afiliación: Clínica Clima/BR / Mayo Clinic/US

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Índice: LILACS (Américas) Asunto principal: Tabaquismo / Cese del Hábito de Fumar / Homosexualidad Femenina Tipo de estudio: Guía de Práctica Clínica / Factores de riesgo Idioma: Inglés Revista: Braz. J. Psychiatry (São Paulo, 1999, Impr.) Asunto de la revista: Psiquiatria Año: 2021 Tipo del documento: Artículo País de afiliación: Brasil / Estados Unidos Institución/País de afiliación: Clínica Clima/BR / Mayo Clinic/US